11/04/2019 14:49:51

Business transacted at annual general meeting and first meeting of the Board of Directors

Company Announcement No. 373, 2019

Business transacted at annual general meeting and first meeting of the Board of Directors

The annual general meeting of H+H International A/S was held on Thursday 11 April 2019 in accordance with the agenda in the notice of 19 March 2019 convening the annual general meeting.

The shareholders in the general meeting adopted the audited annual report for 2018.

In addition, the shareholders at the general meeting passed the following resolutions:

  • to discharge the Board of Directors and the Executive Board from liability;
  • to carry forward the result according to the adopted annual report for 2018 to the next financial year, and that there shall be no payment of dividend;
  • to approve the remuneration of the Board of Directors for 2019;
  • to elect Helen MacPhee and to re-elect Kent Arentoft, Stewart A Baseley, Volker Christmann, Pierre-Yves Jullien and Miguel Kohlmann to the company’s Board of Directors;
  • to re-appoint Deloitte Statsautoriseret Revisionspartner­selskab as the company’s auditor;
  • to authorise the Board of Directors, until the next annual general meeting, to allow the company to acquire treasury shares on an ongoing basis to the extent that the nominal value of the company's total holding of treasury shares at no time exceeds 10% of the company's share capital. The purchase price paid in connection with the acquisition of the treasury shares must not deviate by more than 10% from the most recently quoted market price of the shares on NASDAQ Copenhagen A/S at the time of acquisition; and 
  • to authorise the chairman of the annual general meeting, with a right of substitution, to make such amendments and additions to the resolutions passed by the general meeting and to the application for registration with the Danish Business Authority as the Authority may require for registration.

At the meeting of the Board of Directors held immediately after the annual general meeting, the Board of Directors re-elected Kent Arentoft as its chairman.

For further information please contact Michael T Andersen, CEO, or Bjarne Pedersen, Vice President, Business Development & IR, on telephone +45 35 27 02 00.


Kent Arentoft                                              Michael T Andersen

Chairman of the Board of Directors           CEO

About H+H

H+H is a wall building materials provider. In 2018 H+H had a revenue of DKK 2.5 billion. The parent company H+H International A/S is headquartered in Copenhagen, Denmark, and its shares are listed on Nasdaq Copenhagen.

The core activity is production and sale of autoclaved aerated concrete (AAC or aircrete) and calcium silicate units (CSU or sand lime bricks). The main products are building blocks used for wall building primarily in the residential new building segment. The product range also includes more advanced products such as high-insulating blocks, larger elements and a range of traded goods used for wall building.

H+H employs more than 1,600 employees and has 28 factories in Northern and Central Europe and Northwest Russia with a total annual output of approx.4 million m3 of wall building materials and a leading position in most of its markets. The business is cyclical and H+H is always pursuing organic growth and margin improvements. In addition, restructuring of the markets in Central Europe is on the strategic agenda.



Related content
13 May - 
Interim financial report for Q1 2019
25 Apr - 
H+H in dialogue with potential buyers of its Russian bu..
19 Mar - 
Notice of annual general meeting of H+H International A..
Related debate
26 Apr - 
Der er ikke kommet nye analyser siden sidst.

Post comment

Related debate

  • 1 week
  • 1 month
  • 1 Year
Ingen indlæg


EuroInvestor: In Focus


EuroInvestor: In Focus


EuroInvestor: In Focus

Most read news

  • 24 hours
  • 48 hours
  • 1 week
OSE Immunotherapeutics Will Participate in HealthTech Investor Days (HTID)
Global Arena Holding Inc. (GAHC), Files First Quarter 10Q, and Updates Shareholders on Subsidiaries
Bragar Eagel & Squire, P.C. Announces That a Class Action Lawsuit Has Been Filed Against Eros International Plc (NYSE: EROS) and Encourages Eros Investors to Contact the Firm
Hofseth Biocare ASA: Signed Letter of Intent with Garden of Life® for exclusive use of CollaGo® and ProGo® in the US market
Final Data Analysis of Phase 2 PBC Trial Shows that Genkyotex’s Anti-fibrotic Candidate GKT831 Demonstrated Statistically Significant Improvements in GGT and ALP Over Full Treatment Period

Related stock quotes

H+H International A/S 108.80 0.7% Stock price increasing

Latest news

Copyright Berlingske Media 2019  Cookie- and Privacy policy  |  Cookies  |   General terms of trade  |   Terms of use and IP rights
Quote information is delivered by Morningstar.
Data is delayed 15-20 minutes according to the distribution agreements set by the different exchanges.
24 June 2019 23:31:27
(UTC+00:00) Dublin, Edinburgh, Lisbon, London
Version: LiveBranchBuild_20190527.1 - EUROWEB5 - 2019-06-25 00:31:27 - 2019-06-24 23:31:27 - 1000 - Website: OKAY